1. 3 Things to Know About Novel Treatment Targets for Schizophrenia

2. Overview of Schizophrenia Pathophysiology

3. Interactions Between Symptom Domains of Schizophrenia

4. Schizophrenia A Disease of Brain Circuitry

5. Heterogeneity of Symptoms

6. DSM-5 Criteria for Schizophrenia

7. Rule Out Secondary Causes in Schizophrenia Differential Diagnosis

8. Schizophrenia Time Course

9. Treatment Targets in Schizophrenia

10. Established Treatments Targeting Dopamine

11. Adverse Effects Associated with Dopamine Blockade

12. Newly Approved Antipsychotic Agents

13. Lumateperone in Schizophrenia

14. Pimavanserin in Schizophrenia

15. Trace Amine-Associated Receptor 1 (TAAR1) in Schizophrenia

16. Evaluating Lu AF35700

17. Effects on Symptoms in Schizophrenia MIN-101

18. ENLIGHTEN-1 ALKS 3831

19. ENLIGHTEN-2 ALKS 3831

20. Advantages of New and Novel Agents

21. Glutamatergic Pathways

22. Concluding Remarks

23. Abbreviations